Default: Journal of Neuroimmunology

ISSN: 0165-5728

Journal Home

Journal Guideline

Journal of Neuroimmunology Q2 Unclaimed

Elsevier B.V. Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Neuroimmunology is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 155. It has an SJR impact factor of 0,897 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,897.

Journal of Neuroimmunology focuses its scope in these topics and keywords: multiple, sclerosis, model, icam, antibodies, chronic, brain, polymorphism, progressive, protein, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


Journal of Neuroimmunology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

multiple, sclerosis, model, icam, antibodies, chronic, brain, polymorphism, progressive, protein, response, association, barr, myasthenia, cells, animal, patients, optica, neuromyelitis, cerebrospinal, cytokine, epstein, immune, inflammatory, injury, levels, lymphocyte, adhesion, myelin, neurological, responses,

Best articles by citations

Pituitary adenylate cyclase-activating polypeptides ( PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP

View more

Cytokines and immunity in multiple sclerosis: the dual signal hypothesis

View more

MRI involvement in relapsing remitting MS: Correlation with functional systems and EDSS

View more

Increased deposition of extracellular matrix components in the thymus gland of MDX mouse: correlation with the muscular lesion

View more

Polymorphisms of the promoter region of the tumor necrosis factor a gene and the outcome of MS

View more

Acute unilateral papillitis versus retrobulbar neuritis: Relation to multiple sclerosis

View more

Rejection of xenogeneic glial cells grafted into spinal cord white matter results in bystander demyelination

View more

Clinical and laboratory evaluation op serum complement and of circulating immune complexes in patients with multiple sclerosis

View more

Static urethral pressure profile (S.U.P.P.) or video-dynamic pressure profile (V.D.P.P.) in the evaluation of multiple sclerosis (M.S.)?

View more

Intravenous immunoglobulin (IVIG) for the treatment of progressive multiple sclerosis (MS)

View more

The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra-and intermolecular dominant epitopes

View more

Antibody dependent cell-mediated cytotoxicity - an additional mechanism in human autoimmune myasthenia gravis

View more

Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function

View more

Multiple sclerosis associated with familial Mediterranean fever

View more

Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis

View more

Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor

View more

Prolactin in autoimmunity and antitumor defence

View more


View more

Lytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study

View more

CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis

View more

Affective and schizophrenic syndromes as primary symptoms in multiple sclerosis (MS)?

View more

Induction of myelination in the central nervous system by axonal electrical activity

View more

The effects of recombinant interleukin-1 receptor antagonist (rlL-1ra) on the adoptive transfer of experimental autoimmune encephalomyelitis (EAE) in rats

View more

TGF-beta1-mediated inhibition of glial cell proliferation and down-regulation of ICAM-1 IS interrupted by IFN- gamma

View more